COCRYSTAL PHARMA, INC. Liabilities, Noncurrent
COCRYSTAL PHARMA, INC. (COCP) had Liabilities, Noncurrent of $989.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Noncurrent $989.00K.
- 2026-03-31: Liabilities, Noncurrent $1.08M.
- 2025-12-31: Liabilities, Noncurrent $1.17M.
- 2025-06-30: Liabilities, Noncurrent $1.34M.
| Period end | Liabilities, Noncurrent | Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $989.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.08M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.17M 10-Q · filed 2026-08-13 | |
| 2025-06-30 | $1.34M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.42M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.50M 10-K · filed 2026-03-31 | |
| 2024-06-30 | $1.53M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.58M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $1.61M 10-K · filed 2025-03-31 | |
| 2023-03-31 | $27.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $57.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $119.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $177.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $234.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $298.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $358.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $290.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $336.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $379.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $425.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $480.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $485.00K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $537.00K 10-K · filed 2021-03-17 | |
| 2019-09-30 | $587.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $635.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $718.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $117.00K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $12.13M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $12.63M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $15.23M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $14.59M 10-K · filed 2019-04-01 | $14.62M 10-K · filed 2018-03-21 |
| 2017-09-30 | $20.50M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $20.50M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $20.51M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $20.52M 10-K · filed 2018-03-21 | |
| 2016-09-30 | $49.93M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $49.93M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $49.93M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $49.94M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $65.26M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $65.26M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $65.26M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $65.26M 10-Q · filed 2015-11-16 | |
| 2014-09-30 | $7.24M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $6.45M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $12.09M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $23.00K 10-Q · filed 2014-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |